SIALKOT, Dec 22 (APP): A seminar titled ‘Hemophilia Awareness’ was held here at Govt College Women University Sialkot (GCWUS) to educate participants about its symptoms, treatment options and early ...

December not only marks the end of the year, but it’s also the time for my annual visit to the specialists at my regional hemophilia treatment center (HTC ... As part of my routine check, my doctor ...

North America emerged as the dominant region in the global hemophilia treatment market in 2024. This is driven by a combination of advanced healthcare infrastructure, high disease awareness ...

This, in turn, enhances thrombin production and improves blood clotting. Concizumab-mtci (Alhemo ®) is the first subcutaneous therapy approved by the US Food and Drug Administration (FDA) for the ...

This production improves thrombin generation and clot formation in patients with hemophilia A or B with inhibitors. The approval is supported by data from the multicenter, open-label phase 3 ...

The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce bleeding episodes in patients aged 12 and older. The FDA recently approved ...

Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with those with de novo acral melanoma, according to a study.

Research institutions contribute scientific knowledge and innovation, while patient organizations provide insights into the lived experiences of individuals with hemophilia. By working together ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its once-daily hemophilia injection across the regulatory finish line days ...

In India, there are many cases of haemophilia and the patients often suffer in silence. Hemophilia is a fatal bleeding disorder that stops blood from clotting and is present from birth.